A collaborative research project conducted between The Scripps Research Institute in La Jolla, California; Yale University in New Haven, Connecticut; and National Biotechnology Center in Madrid, Spain, has identified a small molecule called miR-148a as a key regulator of immune cells, where higher levels appear to cause autoimmune diseases. The paper, “…
The Alliance for Lupus Research and The Lupus Research Institute, in conjunction with the Congressional Lupus Caucus, are inviting lawmakers to a lunchtime briefing on the “New Action Plan for Lupus Research” recently released by the National Institute of Arthritis and Musculoskeletal…
The Lupus Foundation of America announced that its 2016 peer-reviewed research funding will include a focus on lupus studies into stem cells, environmental disease triggers, and outcomes in children and teenagers. Applications from researches are now being accepted for the awards, which can range up to $140,000. The foundation will…
How often should you exercise when you have lupus? Research has shown that lupus patients are strong believers in the benefits of exercise, but may not exercise enough over concerns of fatigue, overexposure to sunlight, and injury — legitimate concerns but ones less important than countering the disease’s impact on…
As a celebration for its 37th anniversary of independence, St. Lucia Arthritis and Lupus Association (SLALA) reflects on the journey so many people face by dealing with chronic diseases under the theme “The Journey Continues.” According to a press release, SLALA has created an opportunity for St. Lucians to find a way to…
Ulster University researchers found that mercury exposure through dental fillings or the consumption of seafood does not exacerbate symptoms of systemic lupus erythematous (SLE). While there is a lack of scientific evidence, exposure to mercury is widely believed to trigger SLE in patients who are genetically susceptible. In…
Temple University School of Medicine researchers have discovered how infections cause lupus flares. In a study funded by the Lupus Research Institute (LRI) and the NIH’s National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), Stefania Galluci, PhD, and her team identified a mechanism through which a specific type…
Immunovia AB, together with Lund University in Sweden, will launch a new program to develop, validate, and commercialize antibody array-based tests for differential diagnostics and for prediction and monitoring of systemic lupus erythematosus (SLE) flares. SLE is one of the hardest diseases to diagnose as its symptoms are similar to those…
Systemic lupus erythematosus (SLE) patients with chronic renal failure who are using anticoagulants or antiepileptics are at higher risk for osteoporosis and fragility fractures, according to a study, “Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus,” published in the journal Lupus Science…
Resolve Therapeutics has successfully completed a dose escalation study of its candidate drug RSLV-132 targeting systemic lupus erythematosus (SLE). RSLV-132 works by breaking down the RNA found in immune complexes. Increasing evidence shows the importance of RNA bound to autoantibody immune complexes to activate the inflammatory pathway regulated by interferon. The drug…